A phase II double-blinded study to evaluate the efficacy of EW02 in reducing chemotherapy-induced neutropenia in breast cancer

Author：              

Publisher： Spandidos Publications

E-ISSN： 1792-1082|10|3|1793-1798

ISSN： 1792-1074

Source： Oncology Letters, Vol.10, Iss.3, 2015-01, pp. : 1793-1798

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The efficacy and safety of palonosetron compared with granisetron in preventing highly emetogenic chemotherapy-induced vomiting in the Chinese cancer patients: a phase II, multicenter, randomized, double-blind, parallel, comparative clinical trial

By Yu Zhaocai  

Supportive Care in Cancer, Vol. 17, Iss. 1, 2009-01 ,pp. : 99-102

Springer Publishing Company

Access to resources Recommend Favorite

Prospective assessment of chemotherapy-induced peripheral neuropathy due to weekly paclitaxel in patients with advanced or metastatic breast cancer (CSP-HOR 02 study)

By Kuroi Katsumasa   Shimozuma Kojiro   Ohashi Yasuo   Hisamatsu Kazufumi   Masuda Norikazu   Takeuchi Ayano   Aranishi Toshihiko   Morita Satoshi   Ohsumi Shozo   Hausheer Frederick  

Supportive Care in Cancer, Vol. 17, Iss. 8, 2009-08 ,pp. : 1071-1080

Springer Publishing Company

Access to resources Recommend Favorite

Phase II study evaluating the efficacy and safety of sagopilone (ZK-EPO) in patients with metastatic breast cancer that has progressed following chemotherapy

By Morrow Phuong   Divers Stephen   Provencher Louise   Luoh Shiuh-Wen   Petrella Teresa   Giurescu Marius   Schmelter Thomas   Wang Yao   Hortobagyi Gabriel   Vahdat Linda  

Breast Cancer Research and Treatment, Vol. 123, Iss. 3, 2010-10 ,pp. : 837-842

Springer Publishing Company

Access to resources Recommend Favorite

Oral Ondansetron in the Prevention of Chemotherapy-induced Emesis in Breast Cancer Patients

By Clavel M.   Bonneterre J.   d'Allens H.   Paillarse J.-M.  

European Journal of Cancer, Vol. 31, Iss. 1, 1995-01 ,pp. : 15-19

Elsevier

Access to resources Recommend Favorite

A Southwest Oncology Group Randomized Phase II Study of Doxorubicin and Paclitaxel as Frontline Chemotherapy for Women with Metastatic Breast Cancer

By Lyman Gary   Green Stephanie   Ravdin Peter   Geyer Charles   Russell Christy   Balcerzak Stanley   Thomas Budd G.   Martino Silvana  

Breast Cancer Research and Treatment, Vol. 85, Iss. 2, 2004-05 ,pp. : 143-150

Springer Publishing Company

Access to resources Recommend Favorite